Author

Kensuke Munekage

Observed name: K. Munekage

Observed institutions: Aichi Medical University, Kagawa University, University of Kochi, Kochi Medical School Hospital, Ogaki Municipal Hospital, Kagawa University Hospital, Hata Kenmin Hospital, Kōchi University

ORCID: 0000-0001-8199-9191

Observed ORCID: 0000-0001-8199-9191

OpenAlex ID: A5055170580

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

2022 · Hideki Fujii, Michihiro Iwaki, et al. · Clinical Gastroenterology and Hepatology · 105

Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

2013 · Motoi Hashiba, Masafumi Ono, et al. · PLoS ONE · 61

PDF

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey

2015 · Katsutoshi Tokushige, Hideyuki Hyogo, et al. · Journal of Gastroenterology · 60

Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

2023 · Hirokazu Takahashi, Miwa Kawanaka, et al. · Nutrients · 36

PDF

The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD

2022 · Yoshihiro Kamada, Kensuke Munekage, et al. · Nutrients · 36

PDF

Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study

2024 · Michihiro Iwaki, Hideki Fujii, et al. · Clinical and Molecular Hepatology · 34

PDF

Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice: Roles of PNPLA3 for fatty liver in ER stress

2015 · Tsunehiro Ochi, Kensuke Munekage, et al. · Hepatology Research · 21

Hepatic inflammation and fibrosis are profiles related to mid‐term mortality in biopsy‐proven MASLD: A multicenter study in Japan

2024 · Tsubasa Tsutsumi, Takumi Kawaguchi, et al. · Alimentary Pharmacology & Therapeutics · 19

PDF

Angiotensinogen gene haplotype is associated with the prevalence of Japanese non‐alcoholic steatohepatitis

2011 · Masafumi Ono, Tsunehiro Ochi, et al. · Hepatology Research · 18

Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease

2024 · Kazuhiro Nouso, Miwa Kawanaka, et al. · Hepatology Research · 17

PDF

Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?

2020 · Yoshio Sumida, Masashi Yoneda, et al. · International Journal of Molecular Sciences · 16

PDF

Usefulness of Technetium‐99 m‐2‐methoxy‐isobutyl‐isonitrile liver scintigraphy for evaluating disease activity of non‐alcoholic fatty liver disease

2012 · Kosei Masuda, Masafumi Ono, et al. · Hepatology Research · 14

Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS

2017 · Tsunehiro Ochi, Takumi Kawaguchi, et al. · Scientific Reports · 13

PDF

Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring

2018 · Yusuke Oki, Masafumi Ono, et al. · European Journal of Gastroenterology & Hepatology · 11

Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease

2023 · Hideki Fujii, Makoto Fujii, et al. · Hepatology Research · 10

PDF

Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease

2021 · Yutaro Ogawa, Takashi Nakahara, et al. · Journal of Gastroenterology and Hepatology · 10

Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD

2023 · Hidenori Toyoda, Hideki Fujii, et al. · Gastro Hep Advances · 9

PDF

Noninvasive tests predict liver‐related events and mortality in patients with nonalcoholic fatty liver disease: sub‐analysis of the CLIONE‐Asia study

2023 · Hiroshi Ishiba, Yoshio Sumida, et al. · Journal of Gastroenterology and Hepatology · 7

Importance of ALT levels of >30 in patients with MASLD: Nara Declaration 2023

2024 · Miwa Kawanaka, Hideki Fujii, et al. · Kanzo · 6

PDF

Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning

2023 · Takanori Ito, Hikaru Morooka, et al. · Journal of Gastroenterology and Hepatology · 6

Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia

2022 · Yuya Seko, Miwa Kawanaka, et al. · Journal of Gastroenterology and Hepatology · 6

Serum Mac‐2 binding protein level predicts the development of liver‐related events and colorectal cancer in patients with NAFLD

2022 · Yoshihiro Kamada, Takashi Nakahara, et al. · Hepatology Communications · 5

High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non‐alcoholic fatty liver disease patients before development of diabetes mellitus

2016 · Kosei Masuda, Shuhei Noguchi, et al. · Hepatology Research · 5

Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/L

2025 · Miwa Kawanaka, Hideki Fujii, et al. · Diagnostics · 3

PDF

Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7S

2025 · Hiroshi Ishiba, Yoshio Sumida, et al. · Gastro Hep Advances · 2

PDF

Works count: 38

Citation count: 532

H-index: 13

I10-index: 16